Gregg Visit 1: Screening and Treatment of Chronic Hepatitis C in the Primary Care Setting

Screening and Treatment of Chronic Hepatitis C: Navigating the Evolving Standard of Care
1 ANCC Contract Hours 1 AMA PRA Category 1 Credit(s)™
Launch Date:
Expiration Date:
The accreditation for this activity has expired.

Primary Audience:

No primary audience was provided.

Relevant Terms:

No primary audience was provided.

Robert Lowe, MD

Robert Lowe, MD
Director of Education, Gastroenterology
Assistant Professor of Medicine
Boston University School of Medicine
Boston, MA

Dr. Lowe is an Assistant Professor of Medicine at the Boston University School of Medicine and Educational Director of the Section of Gastroenterology at Boston Medical Center. Dr. Lowe graduated from Harvard College and Harvard Medical School, and completed his residency in internal medicine at the Brigham and Women's Hospital in Boston. He later joined the Gastroenterology faculty at Brigham and Women's Hospital, and recently returned to Boston Medical Center as a faculty member in the Gastroenterology Section. Dr. Lowe's clinical focus is in hepatology, and his practice encompasses all aspects of liver disease. His research interests include the evaluation of new treatments for viral hepatitis, the management of cirrhosis and the complications of advanced liver disease, and the study of fatty liver disorders.

Lorraine Sanphy, RN

Lorraine Sanphy, RN
CNE Course Advisor
Staff Hepatology Nurse
Boston Medical Center
Boston, MA

Ms. Sanphy is the Hepatology Nurse in the Centers for Digestive Disorders Department at Boston Medical Center.  Her clinical responsibilities are focused on case management, patient education, and care coordination of complex medication regimens in patients diagnosed with liver disease. She received her RN diploma from Lynn Hospital School of Nursing. She is currently attending Jacksonville University RN to BSN program.

Raymond T. Chung, MD

Raymond T. Chung, MD
Associate Professor of Medicine
Harvard Medical School
Chief of Hepatology
Director of Liver Center
Massachusetts General Hospital
Boston, MA

Dr. Raymond T. Chung received his medical degree from Yale University School of Medicine. He is an Associate Professor of Medicine at Harvard Medical School and the Director of Hepatology, Massachusetts General Hospital. Highlights of his research interests include hepatitis in special populations, HIV-Hepatitis C virus interactions and pathogenesis, and HCV Virology, HCV RNA testing, HCC biomarkers, PEG-Introm plus Rebetol in hepatitis C, as well as studies of hepatitis B after liver transplantation. He has received numerous teaching and clinical investigator awards. He has served on many NIH panels and editorial boards of peer-review journals.
1. Explain which patients should be screened for HCV infection based on current CDC and USPSTF recommendations
2. Articulate increased confidence in the identification of HCV infection and recognize which patients will or will not likely benefit from use of DAA therapy
3. List the benefits and the risks of existing and new therapeutic agents
4. Recount the characteristics of patients for whom HCV treatment is generally accepted and those for whom the decision must be individualized or is contraindicated